Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pilot, Open-label, Randomized, Single-center Study to Asses a Simplification Strategy From Protease Inhibitors to Raltegravir: Once Daily Isentress (ODIS)

NCT00941083 is registered in ClinicalTrials.gov with Hospital Carlos III, Madrid as lead sponsor.

NCT NCT00941083
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00941083 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pilot, Open-label, Randomized, Single-center Study to Asses a Simplification Strategy From Protease Inhibitors to Raltegravir: Once Daily Isentress (ODIS)
Lead sponsor
Hospital Carlos III, Madrid
Phase
Phase 4
Overall status
Unknown status
Start date
January 31, 2009
Completion date
December 31, 2009
Enrollment
240 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hiv infections